Skip to main content

Kisunla

NDC 0002-9401 · Eli Lilly and Company

Generic namedonanemab-azbt

Dosage formINJECTION, SOLUTION

RouteINTRAVENOUS

Active ingredient(s)DONANEMAB

Strength17.5 mg/mL

Marketing categoryBLA

Packages

0002-9401-01 — 1 VIAL, SINGLE-DOSE in 1 CARTON (0002-9401-01) / 20 mL in 1 VIAL, SINGLE-DOSE

Billed under HCPCS

J0175 — Injection, donanemab-azbt, 2 mg Medicare Part B payment limit (ASP + 6%): $4.17

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels